Omicron RBD-ACE2 binding found to be stronger than wild type SARS-CoV-2 strain
Researchers recently investigated the effect of SARS-CoV-2 Omicron variant mutations on the binding of the receptor-binding domain and angiotensin-converting enzyme-2 to study the overall binding profile of the RBD-ACE2 system.
Aimee Molineux Puwadol Jaturawutthichai Shutterstock Neha Mathur Neha Mathurfeb Binding Interactions Image Credit
Source: news-medical.net